Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1957 1
1958 2
1961 3
1962 6
1963 7
1964 1
1966 1
1969 1
1976 1
1977 1
1983 2
1986 3
1987 3
1989 1
1990 1
1991 2
1992 1
1994 1
1995 2
1996 3
1997 2
1998 3
2000 3
2001 4
2002 2
2003 2
2004 1
2005 6
2006 6
2007 6
2008 8
2009 5
2010 5
2011 10
2012 7
2013 5
2014 11
2015 14
2016 14
2017 4
2018 2
2019 4
2020 5
2021 2
2022 3
2023 7
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Tinterri C, Gentile D, Gatzemeier W, Sagona A, Barbieri E, Testori A, Errico V, Bottini A, Marrazzo E, Dani C, Dozin B, Boni L, Bruzzi P, Fernandes B, Franceschini D, Spoto R, Torrisi R, Scorsetti M, Santoro A, Canavese G; SINODAR-ONE Collaborative Group. Tinterri C, et al. Among authors: bottini a. Ann Surg Oncol. 2022 Sep;29(9):5732-5744. doi: 10.1245/s10434-022-11866-w. Epub 2022 May 12. Ann Surg Oncol. 2022. PMID: 35552930 Clinical Trial.
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D; SINODAR-ONE Collaborative Group. Tinterri C, et al. Among authors: bottini a. Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215. Br J Surg. 2023. PMID: 37471574 Free PMC article. Clinical Trial.
Targeting Influenza A Virus RNA Promoter.
Bottini A, De SK, Wu B, Tang C, Varani G, Pellecchia M. Bottini A, et al. Chem Biol Drug Des. 2015 Oct;86(4):663-73. doi: 10.1111/cbdd.12534. Epub 2015 Mar 13. Chem Biol Drug Des. 2015. PMID: 25676805 Free PMC article.
Purtscher-Like Retinopathy in a Patient with COVID-19.
Bottini AR, Steinmetz S, Blinder KJ, Shah GK. Bottini AR, et al. Case Rep Ophthalmol Med. 2021 Mar 20;2021:6661541. doi: 10.1155/2021/6661541. eCollection 2021. Case Rep Ophthalmol Med. 2021. PMID: 33859855 Free PMC article.
Gene expression profiling in breast cancer: a clinical perspective.
Arpino G, Generali D, Sapino A, Del Matro L, Frassoldati A, de Laurentis M, Pronzato P, Mustacchi G, Cazzaniga M, De Placido S, Conte P, Cappelletti M, Zanoni V, Antonelli A, Martinotti M, Puglisi F, Berruti A, Bottini A, Dogliotti L. Arpino G, et al. Among authors: bottini a. Breast. 2013 Apr;22(2):109-120. doi: 10.1016/j.breast.2013.01.016. Epub 2013 Feb 23. Breast. 2013. PMID: 23462680 Free article. Review.
Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.
Ravelli A, Reuben JM, Lanza F, Anfossi S, Cappelletti MR, Zanotti L, Gobbi A, Milani M, Spada D, Pedrazzoli P, Martino M, Bottini A, Generali D; Solid Tumor Working Party of the European Blood and Marrow Transplantation Society (EBMT). Ravelli A, et al. Among authors: bottini a. Expert Rev Anticancer Ther. 2015 Jun;15(6):689-702. doi: 10.1586/14737140.2015.1042864. Epub 2015 Apr 30. Expert Rev Anticancer Ther. 2015. PMID: 25927868 Review.
174 results